The Wired and Unwell Cascade.

Part 5. The science linking wireless radiation to brain and nervous system harm.

May 26, 2026

Part 5 in a PSGRNZ series:

Across the clinical and review literature on radiofrequency electromagnetic field (RF-EMF) exposure and electrohypersensitivity (EHS), a relatively consistent pattern of neurological and systemic symptoms has been described. These reports span case studies, occupational exposure observations, patient series, and narrative and systematic reviews, including those of Belpomme and Irigaray, Hardell and Nilsson, Stein and Udasin, Leszczynski, Lai, and others.

The symptoms described fall into two broad domains, those experienced as directly neurological or brain-felt, and those that are more diffuse and body-wide, yet the two are not cleanly separable. In most affected individuals they occur together, suggesting a common underlying disturbance rather than a collection of unrelated complaints. Although the terminology varies, many individuals describe symptoms that are experienced as immediate, physically felt, and strongly centred on the nervous system.

The most prominently and consistently reported symptoms are neurological and cognitive in nature. These include headaches, head pressure, burning or tingling sensations in the scalp or face, dizziness, balance disturbance, tinnitus, cognitive slowing, concentration difficulties, short-term memory impairment, and a profound sense of mental fatigue or ‘brain fog’. Sleep disturbance is also frequently reported, including insomnia, fragmented sleep, reduced sleep quality, and unrefreshing sleep.

Some individuals describe a distinctly altered mental state following exposure, characterised by difficulty processing information, reduced attention, sensory overstimulation, or a ‘hungover’ feeling. Mood-related symptoms are also common, including irritability, anxiety, agitation, emotional instability, and depressive symptoms.

Alongside these directly brain-felt experiences, broader body-wide symptoms are also described. These include palpitations, a racing heart, chest discomfort, fatigue, weakness, muscle pain, disrupted regulation of basic body functions, nausea, gastrointestinal disturbance, skin burning or flushing sensations, and general unwellness. In some reports, symptoms resemble an exaggerated stress or inflammatory response, with individuals describing exhaustion, flu-like sensations, internal vibrations, or difficulty tolerating physical exertion. Several reviews note that symptoms often involve multiple organ systems at once, rather than presenting as isolated neurological complaints.

An important feature of this literature is that individuals frequently describe the symptoms as immediate and embodied rather than abstractly psychological. Patients often report sensations such as ‘pressure in the head’, ‘brain buzzing’, ‘internal vibration’, ‘electrical sensations’, or feeling suddenly unable to think clearly. These descriptions recur across geographically and methodologically distinct reports, including recent case series examining exposure associated with modern wireless infrastructure.

Taken together, the symptom patterns described across this literature resemble disturbances in the brain’s core regulatory systems. The reported features are broadly consistent with dysfunction involving neuronal excitability, autonomic regulation, sensory processing, sleep and circadian organisation, and neuroimmune signalling.

The central nervous system (CNS) does not merely “think”. It integrates sensory input, regulates arousal, coordinates the body’s automatic functions, controls sleep–wake timing, modulates immune signalling, and maintains cognitive and emotional stability. When something disrupts this system, the effects are felt across multiple domains at once, which is precisely the pattern that the clinical literature describes.

What is notable about this symptom pattern is not only its breadth but its internal coherence. The symptoms reported across this literature: disrupted sleep, cognitive impairment, mood dysregulation, sensory hypersensitivity, autonomic instability, fatigue, and diffuse pain - are not randomly scattered across the body’s systems.

Rather, they map onto five interconnected regulatory domains of the nervous system: neuronal excitability, whose disruption produces headache, sensory hypersensitivity, and abnormal skin sensations; autonomic regulation, whose disruption accounts for palpitations, cardiovascular variability, and the body’s failure to maintain its internal balance; sensory processing, where altered amplification of signals gives rise to disproportionate and sometimes painful responses to ordinary stimuli such as sound, light, or touch; sleep and circadian organisation, whose disruption cascades through virtually every other system and amplifies cognitive and mood symptoms; and neuroimmune signalling, which when disturbed produces the fatigue, diffuse pain, and inflammatory quality that characterises the body-wide dimension of the illness.

That the reported symptoms map so consistently onto these five domains suggests that whatever the primary biological event may be, it acts at a level that affects multiple regulatory systems at once. This is less consistent with a purely psychological origin and more consistent with a disruption occurring at a fundamental level of brain and cellular function that underlies all of them.

[1] Neuronal excitability.

The healthy central nervous system maintains a precise dynamic balance between excitation and inhibition - between the signals that fire neurons and those that hold them in check. This balance depends on tightly regulated electrical signals across cell membranes, neurotransmitter levels, synaptic communication, and the timing of neural networks. Symptoms such as head pressure, headache, brain fog, cognitive slowing, poor concentration, memory disturbance, irritability, agitation, tinnitus, tingling, internal vibration, and “wired but exhausted” states all resemble the effects of a disrupted balance between excitation and inhibition.

This balance depends on the coordinated activity of excitatory brain chemicals, principally glutamate, and inhibitory ones, principally gamma-aminobutyric acid (GABA). GABA acts as the brain’s principal brake, keeping excitatory activity in check. Hu et al. (2021) review the effects of RF-EMF on brain neurotransmitter levels, signalling, and receptor systems, while Abtin et al. (2024) examine EMF exposure in relation to changes in neural networks, cognitive function, synaptic structure, and hippocampal function.

The evidence indicates that RF-EMF consistently disrupts this excitatory-inhibitory balance. Multiple studies found that radiofrequency exposure reduces glutamate and its breakdown products in the hippocampus, while others found dose-dependent increases, with lower exposures increasing levels and higher ones decreasing them, suggesting a complex, non-linear response rather than a simple dose-dependent effect.

The explanation for these neurotransmitter shifts begins at the cell membrane. RF-EMF radiation can alter the permeability of cell membranes, including their calcium channels, triggering an abnormal rise in calcium inside the cell. Bertagna et al. (2021), in their systematic review of EMF effects on neuronal ion channels, confirmed that the CNS is particularly sensitive to EMF and that these effects operate through calcium-dependent pathways. Since the release of neurotransmitters at synapses itself depends on calcium, this disruption cascades directly into abnormal neurotransmitter signalling. Abtin et al. (2024) further document that EMF exposure affects not just neurons but also glial cells (the brain’s support cells) altering their structure and function in ways that undermine the stable chemical environment that healthy synaptic communication requires.

[2] Autonomic regulation.

The autonomic nervous system, coordinated through brainstem, hypothalamic, limbic, and cortical networks, governs the body’s automatic functions: heart rate, blood vessel tone, breathing, digestion, sweating, temperature control, and the stress response. Reported symptoms such as palpitations, a racing heart, chest tightness, dizziness, nausea, abdominal discomfort, flushing, sweating, weakness, and sudden malaise all fit the pattern of disrupted autonomic control.

Stein and Udasin (2020) document that cardiac and autonomic effects of RF-EMF radiation include measurable changes in heart rate variability and heart muscle structure, with evidence of cellular energy dysfunction, oxidative injury to cardiac muscle, and elevated stress hormones in the blood, findings consistent with a state of over-activated stress signalling.

The cardiovascular symptoms reported by EHS patients: palpitations, irregular heartbeat, disrupted heart rate variability - map directly onto this pattern. Eskandani and Zibaii (2024) note that RF-EMF exposure can adversely affect CNS performance through changes in blood-brain barrier permeability, neurotransmitter levels, calcium channel regulation, myelin structure, antioxidant defences, and metabolic processes, changes that would collectively undermine the brainstem and hypothalamic circuits responsible for keeping the body’s automatic functions in balance.

[3] Sensory processing.

The brain continuously filters incoming sensory information so that normal sound, light, touch, temperature, and body signals do not become overwhelming. The reported symptoms of tinnitus, abnormal sound sensitivity, light sensitivity, burning skin, tingling, scalp sensations, facial heat, internal vibration, and balance disturbance suggest that this filtering process is disrupted - with the brain abnormally amplifying signals that should be routine. This matters because these sensory symptoms are not merely peripheral: they implicate deep brain structures including the thalamus, limbic system, cortex, and brainstem. Belpomme and colleagues specifically report findings suggesting involvement of the limbic system and thalamus, which are central to sensory awareness, arousal, and the brain’s sense of the body’s state (2015; 2020; 2022).

Dopamine, whose metabolism is consistently disrupted by RF-EMF radiation in multiple animal studies reviewed by Hu et al. (2021), plays a key role in filtering sensory information and regulating how much importance the brain attributes to incoming signals. Serotonin, shown to be elevated in the hippocampus and other brain regions following longer-term RF-EMF exposure, contributes to pain modulation, temperature sensitivity, and the setting of sensory thresholds.

Acetylcholine, which is critical for cortical arousal and selective attention, was found to be disrupted across numerous studies, with both its production and its receptor activity showing abnormal patterns following RF-EMF. Disruption of this system would reduce the brain’s capacity to filter sensory input, predictably producing the heightened, sometimes painful sensitivity to sound, light, and touch reported by many EHS individuals.

[4] Sleep and circadian organisation.

Sleep is regulated by the hypothalamus, brainstem, pineal gland, autonomic nervous system, and cortex. Reports of insomnia, fragmented sleep, unrefreshing sleep, early waking, vivid dreams, daytime fatigue, and impaired recovery all point to disrupted brain timing and arousal regulation. In this literature, sleep disturbance is a central feature, as poor sleep amplifies pain, cognitive impairment, emotional instability, immune activation, and disruption of the body’s automatic functions.

Sleep is not a passive state but an actively generated and precisely organised process, dependent on the brain’s internal clocks, the balance between sleep-promoting and wake-promoting brain chemicals, and the brain’s ability to produce the characteristic electrical rhythms, including slow deep-sleep waves, sleep spindles, and REM activity, that define each stage of sleep.

Each of these depends on systems documented to be vulnerable to RF-EMF. Serotonin is the chemical from which melatonin, the body’s master sleep hormone, is made; disruption of serotonin therefore has direct consequences for melatonin production and the regulation of the body’s day-night cycle.

Beyond neurotransmitter disruption, the brain electrical activity evidence from Hu et al. (2021) is directly relevant: RF-EMF exposure has been associated with increased cortical activity, increased brain metabolic rate, a reduction in alpha wave activity, an increase in high-frequency brain activity, increased reaction time, and disrupted sleep-related brain rhythms. Disrupted alpha wave activity is particularly significant, alpha waves represent the brain’s resting rhythm and are fundamental to the transition from wakefulness to sleep; their suppression by RF-EMF would directly impair the ability to fall asleep.

Increased high-frequency brain activity corresponds to a state of heightened arousal, the opposite of what is needed for sleep. The sleep disturbances reported as the most prevalent and severe symptoms in the Hardell and Nilsson (2025) 5G case series are therefore consistent with this well-documented pattern of RF-EMF-induced brain overactivation.

[5] Neuroimmune signalling.

The brain and immune system communicate constantly through specialised brain cells, chemical messengers, the blood-brain barrier, and the body’s stress-response pathways. This interface is increasingly understood to be a critical determinant of brain function, mood, cognition, and the experience of fatigue and pain. Symptoms such as flu-like malaise, inflammatory sensations, fatigue, cognitive fog, headache, sleep disruption, and multisystem sensitivity closely resemble the states produced when immune signalling alters brain function, as happens, for example, during illness or chronic inflammation.

The blood-brain barrier, the specialised structure that controls what passes from the bloodstream into the brain, is documented to be vulnerable to RF-EMF. Eskandani and Zibaii (2024) identify changes in its permeability as a primary adverse effect of RF-EMF on the CNS, and Belpomme and Irigaray (2022) identify neurological disorder with inflammation, oxidative stress, blood-brain barrier disruption, and neurotransmitter abnormalities as the core features of EHS.

The neuroinflammatory state is directly relevant to the fatigue, diffuse pain, and cognitive slowing experienced by affected individuals: these are precisely the symptoms produced by pro-inflammatory cytokine signalling, a phenomenon well-characterised in the context of sickness behaviour and central sensitisation. Abtin et al. (2024) further note that EMF exposure affects gene expression and may change epigenetic regulation through effects on DNA methylation, histone modification, and microRNA biogenesis, potentially leading to biological changes, raising the possibility that the neuroimmune consequences of RF-EMF exposure are not transient but become embedded in gene expression patterns that perpetuate the inflammatory state beyond the period of acute exposure.

These five domains are not independent. They form an interlocking system in which disruption at one level propagates through the others: calcium dysregulation drives oxidative stress, which drives brain inflammation, which further disrupts neurotransmitter levels and receptor function, which alters the excitatory-inhibitory balance, which impairs sensory filtering and sleep, which in turn elevates stress hormones and dysregulates the body’s automatic functions. What the literature presents, in aggregate, is not five separate problems but one interconnected breakdown in the nervous system’s capacity to regulate itself, operating at the molecular, cellular, circuit, and whole-system levels simultaneously.

LESZCZYNSKI – THE QUESTION OF CAUSALITY

A significant methodological challenge running through this entire field was addressed directly by Dariusz Leszczynski, a former scientist at the International Agency for Research on Cancer (IARC), in his review of the scientific evidence on individual sensitivity to electromagnetic fields (Leszczynski 2021). Leszczynski stated that the position adopted by organisations including the WHO EMF Project and ICNIRP, namely that there is no proven causal link between EHS and EMF exposure, rests on an evidence base that is methodologically insufficient to exclude causality.

The studies that have been conducted, predominantly provocation studies in which individuals are exposed to EMF under controlled conditions and asked to report symptoms or detect exposure, have been methodologically inadequate in ways that would prevent them from detecting a real effect even if one existed. They have typically failed to account for variability between individuals in frequency sensitivity, exposure history, and biological response thresholds; they have used exposure durations and conditions that may not replicate real-world chronic exposure; and they have not been guided by any mechanistic model of what biological changes to look for or when to look for them. The negative findings from such studies cannot therefore be used to close the question.

Leszczynski’s proposed way forward is constructive. Rather than continuing provocation studies built around subjective symptom reporting, an approach that has repeatedly failed to resolve the dispute, he argues for research focused on identifying objective biological markers: measurable physical and chemical changes in individuals exposed to EMF that differ systematically from unexposed controls.

This approach acknowledges that if individual sensitivity to EMF exists, it is likely rooted in specific biological characteristics, in the same ion channel behaviour, calcium signalling patterns, oxidative stress markers, neurotransmitter profiles, and immune parameters that the mechanistic literature documents. Finding such markers would do what symptom-based studies have been unable to do: provide an objective, reproducible, biologically grounded basis for determining whether a causal relationship exists and, if so, in whom and under what conditions.

The failure to have pursued this approach represents, in Leszczynski’s assessment, not a verdict on the question, but an indictment of how the question has been studied (Leszczynski 2021).

Mediating Mechanisms: Ion Channels, Neurotransmitters, Oxidative Stress, Calcium Signalling, Glial Activation and the Blood–Brain Barrier

The mechanistic literature reviewed here converges on a sequence of biological events that begins at the cell membrane and propagates outward through calcium signalling, reactive oxygen species (ROS) production, neurotransmitter disruption, glial activation, and ultimately blood–brain barrier (BBB) compromise. While these events have often been discussed as separate phenomena in individual papers, taken together they describe a coherent and interlocking cascade, and the question of what initiates this cascade leads directly to the role of ion channels.

Ion channels as the primary interface

Voltage-gated ion channels (VGICs) are the most abundant class of ion channels in all cell membranes and, as Panagopoulos et al. (2025) argue in their comprehensive mechanistic review, the culmination of work that commenced in 2000, constitute the most sensitive electromagnetic sensors in living organisms (see previous Substack).

Unlike receptor proteins that require specific molecular ligands, VGICs respond to changes in the electrical field across the membrane, precisely the kind of perturbation that polarised, coherent, and variably pulsed anthropogenic EMFs are capable of producing. WC EMFs consist of microwave carrier waves modulated by extremely low frequency (ELF) signals and included in on/off pulses repeated at various ELF rates, and exhibit intense random variability mainly in the ultra-low frequency (ULF) band, making WC EMFs a combination of RF/MW and ELF/ULF EMFs. Note, it is not the gigahertz carrier frequency that matters biologically, it is the slow ELF/ULF variation in the signal. This is also the key to understanding why continuous-wave laboratory studies find no effect: they are testing the wrong thing.

The mechanism by which this occurs is described by Panagopoulos et al. as the Ion Forced Oscillation (IFO)-VGIC mechanism. Mobile ions within VGICs, forced to oscillate by the applied ELF/ULF EMFs, exert forces on the voltage sensors of the VGICs similar to or greater than the forces that physiologically gate those channels, resulting in their irregular gating, i.e., dysfunction. The voltage sensors of VGICs are four symmetrically arranged, positively charged transmembrane helices (S4 subunits); mobile ions in close proximity within the channel pore exert Coulomb forces on these sensors that, when oscillating in a polarised and coherent field, can trigger channel opening or closing at field intensities far below those required to cause tissue heating.

This explains a persistent puzzle in the literature: why studies using simulated, continuous-wave exposures so often find no effect, while studies using real-world pulsed and modulated signals consistently do. These are not contradictory data - they are a consistent signal about the specific characteristics required to trigger the channels.

The low-frequency pulsed and modulated components of wireless signals force ions within voltage-gated ion channels into irregular oscillation, disrupting the gating of all VGICs, including sodium, potassium, chloride, and calcium channels. Calcium dysregulation is the most consequential downstream result, because calcium is the ion through which electrical activity is translated into cellular action, triggering a rise in intracellular calcium that cascades into oxidative stress and neurotransmitter disruption.

The systematic review by Bertagna et al. (2021) corroborates this from the experimental literature, finding that EMF exposure reduces membrane ionic currents in hippocampal neurons through calcium-signalling-dependent pathways, and that these effects are blocked by agents targeting calcium signalling, confirming the VGIC mechanism in neural tissue specifically.
The Abtin et al. (2024) review documents that EMF exposure alters gate dynamics, ion conduction, membrane concentration, and protein expression in glial as well as neuronal cells, confirming that the effect at the membrane level extends beyond neurons to the full cellular architecture of the CNS.
Hu et al. (2021) document that RF-EMF can alter the calcium channels and receptors on the cell membrane and influence transport of calcium ions over the cell membrane, with an increased number of opened calcium channels resulting in increased intracellular calcium concentration under RF-EMF exposure, and that the changes of intracellular calcium levels can trigger unusual synaptic action or cause neuronal apoptosis, which in turn can exert an influence on the neurotransmission of learning and memory processes.

Oxidative stress and its neurological consequences

ROS production is the central biochemical event linking ion channel dysfunction to the full range of downstream effects documented in this literature. Dysfunction of ion channels disrupts intracellular ionic concentrations, which triggers ROS overproduction and oxidative stress (OS) by the ROS-generating systems in the cells, the electron transport chain in the mitochondria, the NADPH/NADH oxidases, the nitric oxide synthases, and others. Panagopoulos et al. (2025) review 131 published studies on oxidative effects of RF/WC EMFs, finding that 124 of them (95%) confirmed statistically significant oxidative effects at non-thermal intensities, a degree of experimental consistency that is rarely matched in biomedical research.

In the CNS specifically, this oxidative burden has direct functional consequences. Hu et al. (2021) document that RF-EMF exposure produces both NO and superoxide, whose combination generates peroxynitrite, and the various oxidants act to produce greatly elevated NF-κB activity, leading to inflammation, with NF-κB signalling reported to be involved in neural immune response, synaptic plasticity, learning and memory, neuroprotection and neurodegeneration.

The downstream consequences for neurotransmitter systems are multiple: oxidative modification of the enzymes responsible for neurotransmitter synthesis and degradation, including monoamine oxidase (MAO), acetylcholinesterase (AChE), and glutamate decarboxylase, would directly alter the concentrations of dopamine, serotonin, norepinephrine, acetylcholine, glutamate and GABA that Hu et al. (2021) systematically document as disrupted by RF-EMF exposure. Oxidative damage to NMDA receptor subunits provides a further mechanistic link between ROS generation and the impaired synaptic plasticity and cognitive deficits observed behaviourally.

Neurotransmitter disruption: An expression of ionic and oxidative dysregulation

The neurotransmitter changes documented across the literature are best understood not as primary effects of RF-EMF but as functional consequences of the upstream membrane and oxidative events described above. Irregular VGIC gating would therefore directly perturb neurotransmitter release kinetics, independent of any effect on neurotransmitter synthesis. Hu et al. (2021) document that transmitter release at synaptic endings is mediated by calcium ion channels, and the modulatory effect of RF-EMF on neurotransmitter levels in various brain regions may play a critical role in brain functioning.

The non-linear, dose-dependent patterns of neurotransmitter change observed across studies, where low-dose exposures sometimes increase and high-dose exposures decrease levels of the same transmitter, are consistent with a system pushed through different phases of compensatory response to an underlying perturbation of calcium-dependent release, rather than with a direct chemical toxicological effect. The disruption of the excitatory-inhibitory balance through concurrent glutamate and GABA alterations, and the documented reductions in NMDA receptor subunit expression, represent the synaptic-level expression of what begins as a membrane-level ionic perturbation.

Glial activation and neuroinflammation

Astrocytes and microglia, the non-neuronal cellular components of the CNS, play essential roles in maintaining the ionic and chemical microenvironment of synapses, clearing glutamate from the synaptic cleft, regulating the BBB, and responding to cellular stress. If EMF exposure promotes oxidative stress or ionic imbalance, glial activation provides a route by which an initially electrophysiological perturbation could become a neuroimmune state. This would fit symptoms such as malaise, fatigue, cognitive fog, sensory sensitivity, headache and sleep disturbance.

Abtin et al. (2024) document that EMF exposure directly affects the structure and function of glial cells, affecting gate dynamics, ion conduction, membrane concentration, and protein expression. Since astrocytes express VGICs and are themselves subject to the IFO mechanism, they would be expected to show calcium dysregulation and ROS overproduction in parallel with neurons. Once activated by oxidative stress and NF-κB signalling, microglia shift toward pro-inflammatory phenotypes, releasing cytokines including IL-1β, IL-6, and TNF-α - the same molecules responsible for the neuroinflammatory symptoms of fatigue, cognitive slowing, pain sensitisation, and mood disturbance. Importantly, astrocytes are responsible for approximately 80% of glutamate reuptake at synapses; their dysfunction under oxidative stress would therefore directly elevate synaptic glutamate, contributing to the excitotoxic pressure and NMDAR dysregulation documented in the experimental literature.

The Blood–brain barrier ‘compromise’.

BBB is not merely a physical barrier but a dynamic neurovascular regulatory interface that preserves ionic homeostasis, controls inflammatory access to the brain and supports neuronal signalling. The BBB is maintained by tight junctions between specialised endothelial cells, supported by astrocytic end-feet and pericytes. Its integrity depends on the normal function of the same ion channels and calcium-dependent signalling pathways disrupted by RF-EMF. Eskandani and Zibaii (2024) identify BBB permeability changes as a primary adverse CNS effect of RF-EMF exposure, and Belpomme and Irigaray (2022) list BBB opening as one of the defining pathophysiological features of EHS alongside inflammation and oxidative stress.

Experimental RF-EMF studies have reported BBB permeability changes, albumin leakage, tight-junction alteration and endothelial signalling effects. If replicated across exposure conditions, such changes could provide a biologically coherent route from external electromagnetic exposure to neurovascular stress, glial activation, altered neurotransmission, sensory disturbance, cognitive impairment and sleep disruption. In this framework, BBB disruption is not an isolated endpoint, but part of a wider CNS regulatory cascade involving calcium signalling, oxidative stress, endothelial function and neuroimmune activation.

The consequence of BBB disruption is a loss of the chemical isolation that the brain requires: serum proteins, immune cells, and neurotoxic substances that would normally be excluded from the parenchyma gain access to neural tissue, further amplifying neuroinflammatory and oxidative processes already initiated at the ion channel level. This creates a third amplification loop, additional to the calcium–ROS and ROS–ion channel feedback cycles, in which BBB compromise worsens the neuroinflammatory environment that itself damages the BBB.

The IFO-VGIC mechanism as a common mediator

The question of whether ion channel activation constitutes a common mediator across all the downstream effects described in this literature can now be addressed directly. The IFO-VGIC (Panagopoulos et al 2025) mechanism and the consequent oxidative stress constitute a comprehensive mechanism that explains all known adverse biological and health effects reported to be induced by anthropogenic EMFs. The case for this is substantial. Every downstream effect discussed in the literature - calcium dysregulation, ROS overproduction, neurotransmitter disruption, NF-κB activation and neuroinflammation, glial activation, and BBB compromise - can be traced mechanistically to upstream VGIC dysfunction. No competing mechanism offers an equivalent explanatory scope at non-thermal exposure levels.

Furthermore, the IFO-VGIC mechanism makes a specific, physically grounded prediction about which signal characteristics will be bioactive, namely pulsed, modulated, polarised, low-frequency-varying fields, that is confirmed by the consistent observation that real-world WC EMFs produce effects that simulated continuous-wave signals do not. This resolves, rather than deepens, the apparent contradictions in the experimental literature.

What unifies the diverse neurological, autonomic, sensory, sleep, and neuroimmune disruptions documented across this corpus is therefore a single initiating event: the irregular gating of voltage-gated ion channels in neural and glial cell membranes by the ELF/ULF components of pulsed, modulated anthropogenic electromagnetic fields.

Everything downstream, the calcium floods, the ROS cascades, the neurotransmitter imbalances, the microglial activation, the barrier failure, follows from this initial perturbation with biophysical and biochemical logic that the mechanistic literature is now sufficiently mature to describe. The clinical symptoms reported by affected individuals are, on this reading, not mysterious or implausible: they are the predictable functional expression of a disruption that begins at the most fundamental level of cellular electrical regulation.

Individual Susceptibility: Why Some People Are More Affected Than Others

Not everyone exposed to the same electromagnetic environment develops symptoms, and this variability is one of the features most often cited to argue against a causal role for EMF. In fact, differential susceptibility is a feature of virtually every environmental exposure, to pollutants, allergens, pathogens, and pharmaceutical agents, and its existence tells us something about individual biology, not about whether a stimulus is real. The question is what determines who is vulnerable.

Several overlapping factors are likely relevant. At the physiological level, Belpomme and Irigaray’s clinical work across a large cohort of EHS patients has identified a consistent set of measurable biological abnormalities that distinguish affected individuals from the general population (2015; 2020; 2022). These include inflammation-related elevated histamine, oxidative stress markers including nitrotyrosine as a marker of peroxynitrite production and BBB opening, protein S100B as a further marker of BBB disruption, and heat shock proteins HSP27 and HSP70 as indicators of cellular stress. The melatonin metabolite 6-hydroxymelatonin sulphate was found to be consistently reduced in affected individuals, pointing to disruption of pineal function and circadian regulation. Circulating autoantibodies against O-myelin were detected in 23% of cases, suggesting that in a significant subgroup the condition involves an autoimmune response.

Taken together, these findings suggest that individuals who develop EHS symptoms may already have - or may develop, a state of elevated neuroinflammation, oxidative load, and BBB vulnerability that makes them more sensitive to further perturbation by EMF exposure. The biological terrain, in other words, matters as much as the exposure.

At the molecular and genetic level, Leszczynski has argued in his 2025 proteomics paper that the key to understanding individual susceptibility lies in precisely this terrain, and that it will only be revealed by looking at it directly. Individual sensitivity to wireless radiation exists in the same way, as other individual sensitivities to environmental factors, and the relevant differences between sensitive and non-sensitive individuals are likely encoded in their protein expression profiles in the specific constellation of ion channel isoforms they express, the efficiency of their antioxidant defence systems, the reactivity of their neuroimmune signalling, and the baseline integrity of their BBB. High-throughput omics approaches, proteomics, metabolomics, and transcriptomics applied in parallel, are, in Leszczynski’s view, the only methodology capable of capturing this complexity. The limited proteomics work conducted to date hints at changes in stress-response proteins, inflammatory mediators, and metabolic regulators in EMF-exposed cells, but no systematic human study has yet been conducted. EHS is not unique in relying on subjective symptom descriptions for diagnosis, the same is true of pain medicine and, closely analogously, of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, and similar efforts to identify objective biomarkers would be beneficial in the study of EHS. (Leszczynski 2025; Leszczynski and de Vocht 2025).

The picture that emerges is of a condition in which susceptibility is continuous, shaped by the interaction of baseline inflammatory and oxidative status, genetic variation in ion channel and antioxidant gene expression, the integrity of the BBB at the time of exposure, and cumulative prior EMF exposure history. Some individuals may sit close to a threshold of neurobiological tolerance that others do not approach, and in those individuals the same exposure that passes without consequence in the majority produces the cascade - calcium dysregulation, ROS overproduction, neurotransmitter disruption, neuroimmune activation, that the mechanistic literature describes. Understanding this threshold, and the individual characteristics that determine it, is both the scientific and clinical priority that the biomarker and proteomics research agenda is designed to address.

CONCLUSION

The evidence reviewed in this paper traces a coherent path from biophysics to lived experience. The low-frequency pulsing and modulation embedded within modern wireless signals, not the carrier frequency itself, are capable of forcing irregular gating across the full ensemble of voltage-gated ion channels in cell membranes throughout the nervous system. This single initiating event drives calcium dysregulation, oxidative stress, neuroinflammation, neurotransmitter disruption, glial activation, and blood-brain barrier compromise, five interlocking regulatory domains whose simultaneous failure accounts, with biological precision, for the headaches, sleep disruption, cognitive impairment, sensory hypersensitivity, mood disturbance, autonomic instability, and systemic fatigue consistently reported by people experiencing electrohypersensitivity and microwave syndrome.

The mechanistic picture is consistent: 95% of experimental studies on oxidative effects confirm it (Yakymenko et al. 2016; Panagopoulos et al 2025), the ion channel literature corroborates it, and the clinical biomarker work of Belpomme and colleagues gives it measurable, objective correlates in affected individuals. That not everyone is equally affected reflects the biology of individual susceptibility, differences in ion channel expression, antioxidant capacity, baseline inflammatory load, and BBB integrity, not an absence of effect. The institutional consensus that no causal link has been established rests, as Leszczynski has demonstrated, on studies too methodologically limited to detect one, and on systematic reviews whose design, as Melnick et al. (2025) have shown, consistently excludes the evidence most likely to find it. What this body of literature establishes is not proof of causation in the legal or regulatory sense, but a scientifically credible, mechanistically grounded, and clinically documented case that something real is happening, and that the frameworks currently relied upon to protect the public were not built to see it.

Part 5 in a PSGRNZ series:

REFERENCES

Abtin S, Seyedaghamiri F, Aalidaeijavadi Z et al. A review on the consequences of molecular and genomic alterations following exposure to electromagnetic fields: Remodeling of neuronal network and cognitive changes Brain Research Bulletin 217:111090 https://doi.org/10.1016/j.brainresbull.2024.111090

Belpomme D, Campagnac C, Irigaray P. Reliable disease biomarkers characterizing and identifying electrohypersensitivity and multiple chemical sensitivity as two etiopathogenic aspects of a unique pathological disorder. Rev Environ Health. 2015;30(4):251-71. doi: 10.1515/reveh-2015-0027. PMID: 26613326.

Belpomme & Irigaray (2020) Electrohypersensitivity as a Newly Identified and Characterized Neurologic Pathological Disorder: How to Diagnose, Treat, and Prevent It. International Journal of Molecular Sciences DOI: 10.3390/ijms21061915

Belpomme D, Irigaray P (2022). Why Electrohypersensitivity and Related Symptoms Are Caused by Non-Ionizing Man-Made Electromagnetic Fields: An Overview and Medical Assessment. Environmental Research. Volume 212, Part A, September 2022, 113374. https://doi.org/10.1016/j.envres.2022.113374

Bertagna, F., Lewis, R., Silva, S.R.P., McFadden, J. and Jeevaratnam, K. (2021), Effects of electromagnetic fields on neuronal ion channels: a systematic review. Ann. N.Y. Acad. Sci., 1499: 82-103. https://doi.org/10.1111/nyas.14597

Eskandani R and Zibaii MI, Unveiling the biological effects of radio-frequency and extremely low frequency electromagnetic fields on the central nervous system performance. BioImpacts. 2024;14(4):30064 doi: 10.34172/bi.2023.30064

Hardell, L and Nilsson, M. Summary of seven Swedish case reports on the microwave syndrome associated with 5G radiofrequency radiation. Reviews on Environmental Health, vol. 40, no. 1, 2025, pp. 147-157. https://doi.org/10.1515/reveh-2024-0017

Hu C, Zuo H and Li Y (2021) Effects of Radiofrequency Electromagnetic Radiation on Neurotransmitters in the Brain. Front. Public Health 9:691880. doi: 10.3389/fpubh.2021.691880

Lai H 2014. Neurological Effects of Non-Ionizing Electromagnetic Fields 2014 Supplement. Prepared for the BioInitiative Working Group

Leszczynski D. Review of the scientific evidence on the individual sensitivity to electromagnetic fields (EHS). Reviews on Environmental Health. 2022 Sep;37(3):423-450. DOI: 10.1515/reveh-2021-0038. PMID: 34229366.

Leszczynski D (2025) Wireless radiation and health: making the case for proteomics research of individual sensitivity. Front. Public Health 12:1543818. doi: 10.3389/fpubh.2024.1543818

Leszczynski D, de Vocht F. Editorial: Individual sensitivity to wireless radiation. Front Public Health. 2025 Dec 5;13:1744897. doi: 10.3389/fpubh.2025.1744897.

Melnick RL, Moskowitz JM, Héroux P, Mallery-Blythe E, McCredden JE, Herbert M, Hardell L, Philips A, Belpoggi F, Frank JW, Scarato T, Kelley E; International Commission on the Biological Effects of Electromagnetic Fields (ICBE-EMF). The WHO-commissioned systematic reviews on health effects of radiofrequency radiation provide no assurance of safety. Environ Health. 2025 Oct 2;24(1):70. doi: 10.1186/s12940-025-01220-4.

Pall, M.L., 2016. Microwave frequency electromagnetic fields (EMFs) produce wide- spread neuropsychiatric effects including depression. J. Chem. Neuroanat. 75 (Pt B), 43–51. http://dx.doi.org/10.1016/j.jchemneu.2015.08.001.

Panagopoulos DJ, Yakymenko I, De Iuliis GN, Chrousos GP. A comprehensive mechanism of biological and health effects of anthropogenic extremely low frequency and wireless communication electromagnetic fields. Front Public Health. 2025 Jun 4;13:1585441. doi: 10.3389/fpubh.2025.1585441.

Stein Y, Udasin IG. Electromagnetic hypersensitivity (EHS, microwave syndrome) – Review of mechanisms. Environmental Research. 2020;186:109445. doi:10.1016/j.envres.2020.109445.

Discussion about this post

Ready for more?